Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 5.990% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCCCN(C(=O)C1CCCC1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
b.) Cc1cc(=O)n2[nH]c(-c3ccc(C(C)(C)C)cc3)cc2n1
Answer: a. CCCCN(C(=O)C1CCCC1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)C1CCCC1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
CCCCN(C(=O)C1CCCC1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
N-[4-amino-3-(2-methylpropyl)-2,6-dioxopyrimidin-5-yl]-N-butylcyclopentanecarboxamide